NEXPHORIA
AOD-9604
HGH fragment 177–191. Lipolytic activity without diabetogenic effects.
Purchase Type
Fresh cold-chain delivery every 30 days
Format
For Research Use Only — Not For Human Consumption
This compound is sold exclusively for qualified research purposes. Not approved by the FDA for therapeutic use.
AOD-9604 is a synthetic analog of the C-terminal fragment (amino acids 177–191) of human growth hormone (hGH). Developed by researchers at Monash University and licensed to Metabolic Pharmaceuticals, it was designed to isolate the anti-obesity effects of GH from its growth-promoting (IGF-1-stimulating) and diabetogenic properties.
Complete Your Protocol
Related compounds.
Side-by-Side Analysis
Compare AOD-9604 with Similar Compounds
View purity, MW, storage, and pricing side by side.
Frequently Bought Together
Complete Your Protocol
Researchers commonly order these compounds together. Convenient multi-compound ordering.
Weight Management
This itemAOD-9604
5mg
$53
Weight Management
RecommendedSemaglutide
5mg
$78
Recovery & Healing
BPC-157
5mg
$50
3 items selected
Uncheck any item to customize your bundle. Discount applied automatically at checkout.
Research Journal
Related Research Articles
AOD-9604 and Lipolysis: The Complete Research Protocol Guide
Comprehensive protocol guide for AOD-9604 (hGH fragment 176-191): β3-adrenergic/cAMP/HSL lipolytic mechanism, Heffernan 1999 DIO mouse dose-response data, adipogenesis inhibition, METABOLICA Phase 2b context, head-to-head vs hGH, reconstitution protocol with disulfide precautions, and six research design considerations.
HGH Fragment 176-191 vs AOD-9604: What's the Difference?
A research clarification on HGH Fragment 176-191 and AOD-9604 — naming conventions, structural differences, lipolytic mechanism, divergent research data, and which designation to use in your protocol.
GLP-1 Receptor Agonists: The Complete Research Landscape
A comprehensive research review of the GLP-1 receptor agonist class — semaglutide, tirzepatide, retatrutide, and liraglutide. Covers incretin physiology, GLP-1R structure and signaling, comparison table across agonists, cardiovascular outcomes data, rodent PK/PD models, and research design considerations.
Complete Your Protocol
Metabolic Research Stack
AOD-9604's lipolytic fragment pairs with Semaglutide's GLP-1 signaling for a multi-pathway metabolic and satiety research design.
Weight Management
AOD-9604
5mg
$53
Weight Management
Semaglutide
5mg
$78